Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $9352.4.

  • Abivax's Capital Expenditures rose 10273.83% to $9352.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $683901.0 for FY2024, which is 13857.97% up from last year.
  • Abivax's Capital Expenditures amounted to $9352.4 in Q3 2025, which was up 10273.83% from -$21507.2 recorded in Q2 2025.
  • Over the past 5 years, Abivax's Capital Expenditures peaked at $1.3 million during Q4 2024, and registered a low of -$341546.3 during Q3 2024.